LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

Home・Listă Acțiuni・NeoGenomics Inc

NeoGenomics Inc

Închisă

8.96 -1.1

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

8.8

Maxim

8.97

Indicatori cheie
By Trading Economics
Venit	-7.2M -17M
Vânzări	-3.5M 187M
EPS	0.01
Marjă de profit	-9.164
Angajați	2,500
EBITDA	-5.8M -567K

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+66.74% upside

Dividende
By Dow Jones
Următoarele câștiguri	28 iul. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	51M 1.2B
Deschiderea anterioară	10.06
Închiderea anterioară	8.96

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

7.7 / 10.27 Suport & Rezistență

NeoGenomics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

7 mai 2026, 21:03 UTC

Câștiguri

Coinbase Global Swings to Loss Amid Softer Crypto Market

6 mai 2026, 18:06 UTC

Principalele dinamici ale pieței

Core Scientific Shares Rise on AI Data Center Expansion Plan

8 mai 2026, 17:04 UTC

Market Talk

Zcash Caps Off Parabolic Week -- Market Talk

8 mai 2026, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

8 mai 2026, 15:20 UTC

Market Talk

'Altcoin Season' Indicator on the Rise -- Market Talk

8 mai 2026, 15:05 UTC

Market Talk

Bitcoin Slips Back Below the $80k Mark -- Market Talk

8 mai 2026, 12:19 UTC

Câștiguri

Bitcoin Price Dives Below $80,000. This Jobs Report Could End the Crypto Slump. -- Barrons.com

8 mai 2026, 10:55 UTC

Market Talk

Bitcoin Edges Higher as Risk Sentiment Improves Slightly -- Market Talk

8 mai 2026, 08:41 UTC

Câștiguri

Coinbase Misses Earnings and Revenue Estimates. The Stock Is Falling. -- Barrons.com

8 mai 2026, 06:25 UTC

Market Talk

Bitcoin Falls as U.S. and Iran Trade Attacks -- Market Talk

7 mai 2026, 21:25 UTC

Câștiguri

IREN 4Q Rev $144.80M >IREN

7 mai 2026, 20:22 UTC

Câștiguri

Coinbase Misses on Earnings and Revenue. The Stock Is Falling. -- Barrons.com

7 mai 2026, 14:30 UTC

Market Talk

Tokenized Assets Saw 22% Market Cap Jump in April -- Market Talk

7 mai 2026, 14:25 UTC

Market Talk

Stablecoin Market Cap Finds New High in April -- Market Talk

7 mai 2026, 11:43 UTC

Market Talk

Bitcoin's Rally Pauses as Investors Remain Cautious Over Iran War -- Market Talk

7 mai 2026, 07:00 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

7 mai 2026, 07:00 UTC

Market Talk

Bitcoin Eases Slightly After Rally on Iran-U.S. Peace Deal Hopes -- Market Talk

7 mai 2026, 06:00 UTC

Câștiguri

Coinbase Heads Into Earnings Facing a Crypto Trading Slowdown -- Barrons.com

6 mai 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

6 mai 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 mai 2026, 18:46 UTC

Câștiguri

Achiziții, Fuziuni, Preluări

Strategy Posts $14.5 Billion Loss on Bitcoin Holdings. The 'Never Sell' Mantra Fades. -- Barrons.com

6 mai 2026, 17:10 UTC

Market Talk

Coinbase Perpetual Gold and Silver Futures Go Live -- Market Talk

6 mai 2026, 16:35 UTC

Market Talk

Major Crypto Assets Show Volatility as War-Ending Deal Mulled -- Market Talk

6 mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

6 mai 2026, 15:12 UTC

Market Talk

Strong Gains in Privacy Coins May Signal Developing Altcoin Demand -- Market Talk

6 mai 2026, 14:55 UTC

Market Talk

CME Launching Bitcoin Volatility Futures -- Market Talk

6 mai 2026, 14:11 UTC

Câștiguri

Achiziții, Fuziuni, Preluări

Strategy Posts $14.5 Billion Loss on Bitcoin Holdings. The 'Never Sell' Mantra Fades. -- Barrons.com

6 mai 2026, 13:59 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 mai 2026, 13:59 UTC

Market Talk

Cryptocurrency Breaks Out as Optimism Over War Grows -- Market Talk

6 mai 2026, 11:05 UTC

Câștiguri

Strategy Posts Wider Loss as Bitcoin Holdings Hit $64 Billion. The Stock Rises Anyway. -- Barrons.com

Comparație

Modificare preț

NeoGenomics Inc Așteptări

Obiectiv de preț

By TipRanks

66.74% sus

Prognoză pe 12 luni

Medie 14.94 USD 66.74%

Maxim 25 USD

Minim 11 USD

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruNeoGenomics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

12 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 12 analiști care au acordat evaluări ale acțiunilor NeoGenomics Inc - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

7.7 / 10.27Suport & Rezistență

Recent bearish events outweigh bullish events.

All events are bearish.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.